Peter A. Socarras
About Peter A. Socarras
Peter A. Socarras serves as the Vice President, General Counsel, and Corporate Secretary at Nevro, where he leads the company's global intellectual property strategy and manages its ESG initiatives. With over 20 years of experience in legal and medical device sectors, he has played a key role in advancing therapies for chronic pain conditions.
Work at Nevro
Peter A. Socarras currently serves as the Vice President, General Counsel, and Corporate Secretary at Nevro, a position he has held since 2024. His responsibilities include managing the company's environmental, social, and governance (ESG) strategy and overseeing litigation across various domains, such as intellectual property and corporate securities. Prior to his current role, he held multiple positions at Nevro, including Senior Director of Intellectual Property, Director of Intellectual Property, and Vice President & Deputy General Counsel for Intellectual Property and Litigation. His extensive experience at Nevro spans over a decade, contributing to the company's legal and strategic initiatives.
Education and Expertise
Peter A. Socarras holds a Juris Doctor (JD) from The George Washington University Law School, obtained between 2003 and 2007. He also earned both a Master of Science (MS) and a Bachelor of Science (BS) in Biomedical Engineering from the University of Miami, completing his studies from 1998 to 2002. His educational background provides a strong foundation in both law and biomedical engineering, enhancing his expertise in intellectual property law within the medical device sector.
Background
Peter A. Socarras began his legal career as a Patent Agent at Cordis Neurovascular in 2003. He later worked at Sterne, Kessler, Goldstein & Fox, where he served as both a Registered Patent Agent and a Patent Attorney from 2004 to 2010. His experience includes advising founders, boards, and investors in the Life Sciences ecosystem. Additionally, he has been involved in various roles that focus on reducing suffering through medical innovations, particularly in the Life Sciences sector.
Achievements
Throughout his career, Peter A. Socarras has been instrumental in bringing therapies to market at Nevro that significantly improve the lives of patients with chronic pain conditions. He has led teams through complex challenges, including raising venture capital, navigating initial public offerings (IPOs), and litigating against major competitors. His leadership in global intellectual property strategy encompasses U.S. and foreign prosecution and adversarial matters, showcasing his extensive experience in the legal aspects of the medical device industry.
Current Involvement and Investments
In addition to his role at Nevro, Peter A. Socarras is an active member of 𝖧𝖭𝖡𝖠/𝖵𝖨𝖠 PODER25, participating in the Class of 2022. He also serves as an Angel Investor with Life Science Angels, where he invests in both public and private companies developing innovations in the Life Sciences. His involvement in these organizations reflects his commitment to supporting the development of medical innovations and contributing to the Life Sciences ecosystem.